Hassan El-Shirbiny

Dr. Hassan El-Shirbiny

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2025 in Oxford Medical Case Reports
Verified
Journal Article
Open access
MGMahmoud Gomaa
Mahmoud Gomaa
HEHassan El-Shirbiny
Hassan El-Shirbiny
OEOsama Elshaer
Osama Elshaer
Background: Acromegaly is an endocrine disorder characterized by excessive growth hormone (GH) production, causing abnormal bone and tissue enlargement. Typically, it presents with distinct physical changes, but some cases may lack noticeable features and still have internal abnormalities like aortic root dilation. Though rare, a family history can raise suspicion. Case presentation: This report presents a case of a 23-year-old male with no significant medical history, who presented with severe dyspnea after a chest infection. He lacked distinct physical features of genetic or endocrinal disorders, but his uncle had acromegaly. Echocardiography revealed left ventricular hypertrophy and massive aortic root dilation. Elevated insulin-like growth factor 1 (IGF-1) confirmed the diagnosis of acromegaly. The patient underwent a Bentall procedure, and his acromegaly was managed with octreotide and regular follow-ups. Conclusions: The report emphasizes the potential genetic link, and the possibility of massive aortic root dilation associated with acromegaly.

2 July 2026 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
HEHassan El-Shirbiny
Hassan El-Shirbiny
MKMoneeb Khalaph
Moneeb Khalaph
PSPhilipp Sommer
Philipp Sommer
CSChristian Sohns
Christian Sohns
Background: Nodoventricular accessory pathways are rare connections between the atrioventricular (AV) node and ventricular myocardium, typically exhibiting decremental conduction and often mimicking AV nodal re-entrant tachycardia. Their diagnosis remains challenging, particularly in the absence of manifest pre-excitation. Case summary: A 30-year-old male with recurrent paroxysmal supraventricular tachycardia (SVT) underwent an electrophysiological study. Electrocardiogram showed no pre-excitation. Pacing manoeuvres revealed concentric, decremental ventriculoatrial conduction, with no evidence for dual AV conduction. Adenosine induced complete anterograde and retrograde block. The tachycardia is induced during programmed atrial stimulation with eccentric coronary sinus activation. The tachycardia is terminated during ventricular overdrive pacing by a fusion beat as well as ventricular extrastimulation without atrial capture in a transition zone, which supports the diagnosis of a nodoventricular accessory pathway with left-sided extension participating in orthodromic AV re-entrant tachycardia. A successful ablation was done on the left posterolateral aspect of the mitral annulus with no further tachycardia induction. Discussion: Nodoventricular accessory pathways remain an important but often concealed cause of SVT. This case highlights a rare presentation involving left-sided extension and demonstrates how detailed electrophysiological assessment can distinguish this entity from other tachycardias. Consideration of this mechanism is essential to ensure accurate diagnosis and safe therapeutic decision-making.

24 August 2026 in Heart Rhythm
Verified
Journal Article
Open access
HEHassan El-Shirbiny
Hassan El-Shirbiny
MKMoneeb Khalaph
Moneeb Khalaph
PLPhilipp Lucas
Philipp Lucas
RBReda Biomy
Reda Biomy
ISIslam Saboukh
Islam Saboukh
PSPhilipp Sommer
Philipp Sommer

18 May 2026 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Open access
ANAhmed Nazmy
Ahmed Nazmy
HEHassan El-Shirbiny
Hassan El-Shirbiny
AAAlaa Abdrabou Abouelmagd
Alaa Abdrabou Abouelmagd
NHNoha Hammad
Noha Hammad
SSSamar Mohamed Sadek
Samar Mohamed Sadek
PSPhilipp Sommer
Philipp Sommer
Catheter ablation is an established therapy for ventricular tachycardia (VT); however, hemodynamic instability frequently limits procedural mapping and success. Temporary mechanical circulatory support (tMCS) devices are increasingly used to maintain end‐organ perfusion during VT ablation, yet their impact on clinical outcomes remains uncertain. We aimed to evaluate the impact of tMCS on clinical outcomes and periprocedural complications in patients undergoing VT ablation. A systematic search of PubMed/MEDLINE, Scopus, Web of Science, and Cochrane CENTRAL was conducted from database inception through December 2025. We included observational studies enrolling adult patients undergoing VT ablation with tMCS, compared with VT ablation performed without MCS. Primary outcomes were all‐cause mortality, in‐hospital mortality, procedural success, VT recurrence, and major adverse cardiovascular events (MACE). Ten observational studies comprising 16,838 patients were included, of whom 1402 received tMCS. There was no significant difference in all‐cause mortality between tMCS and no‐MCS groups (RR 1.71, 95% CI 0.68 to 4.26), procedural success (RR 1.05, 95% CI 0.92 to 1.21), VT recurrence (RR 0.99, 95% CI 0.80 to 1.22), or MACE (RR = 0.79, 95% CI: 0.62 to 1.01). However, tMCS use was associated with significantly higher in‐hospital mortality (RR 7.41, 95% CI 4.77 to 11.66). The tMCS group also demonstrated increased risks of stroke, pericardial effusion or tamponade, and periprocedural complications. In non‐randomized studies, tMCS during VT ablation was not associated with improved long‐term outcomes, while higher in‐hospital mortality and complications likely reflected patient selection and timing of support rather than adverse device effects.

4 July 2024 in The Egyptian Heart Journal
Verified
Journal Article
Open access
PDF file
HEHassan El-Shirbiny
Hassan El-Shirbiny
RBReda Biomy
Reda Biomy
WHWael Anwar Haseeb
Wael Anwar Haseeb
ISIslam Saboukh
Islam Saboukh
Background: Anxiety and depression are potentially harmful outcomes of permanent cardiac pacemakers. Dual-chamber P.P.M. is frequently used to treat life threatening bradycardia. The study aims to estimate the effect of the right ventricular PM lead position on recipients’ anxiety and depression before, 6 months, and 1 year after implantation. Results: A statistically significant correlation was discovered between the studied groups regarding HADS depression score after 6 months (p 0.013) and 1 year (p 0.013). A statistically non-significant difference was found among the studied groups at any point of time regarding baseline (p 0.063), after 6 months (p 0.054), or after 1 year (p 0.099). Significance was found between HADS anxiety score (p 0.015) or depression score after 1 year and the incidence of complications (p 0.001). Conclusions: A strong relationship was found between the level of depression and the R.V. site of implantation, as patients with the apical group had higher levels of depression post-implantation. The septal position has less stress and depression on the patient’s well-being than the apical one.

11 August 2026 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Open access
PDF file
EMElsayed S. Moubarak
Elsayed S. Moubarak
AGAhmed Farid Gadelmawla
Ahmed Farid Gadelmawla
AMAlMothana Manasrah
AlMothana Manasrah
AMAnas Mansour
Anas Mansour
MEMohamed S. Elgendy
Mohamed S. Elgendy
HEHassan El-Shirbiny
Hassan El-Shirbiny
Background: In Wolff–Parkinson–White (WPW) syndrome, accurate localization of accessory pathways before catheter ablation can improve procedural planning and efficiency. Several 12‐lead electrocardiographic (ECG) algorithms have been proposed, but their diagnostic performance has not been consistently established. We performed a systematic review and meta‐analysis to assess the accuracy of ECG‐based algorithms for accessory pathway localization in manifest WPW. Methods: Following PRISMA‐DTA recommendations, PubMed, EMBASE, Cochrane CENTRAL, Web of Science, and Scopus were searched from January 1990 to January 2026. Studies enrolling adult or pediatric patients with manifest pre‐excitation who underwent electrophysiological study (EPS) and catheter ablation were included. Successful localization during EPS/ablation served as the reference standard. Random‐effects models were used to calculate pooled diagnostic accuracy, sensitivity, specificity, and diagnostic odds ratios (DOR). Summary receiver operating characteristic and leave‐one‐out sensitivity analyses were also performed. Results: Seventeen studies involving 3159 patients met inclusion criteria. The pooled diagnostic accuracy of ECG algorithms was 0.91 (95% CI 0.85–0.94), although heterogeneity was substantial (I 2 = 91.4%). Pooled sensitivity was 0.87 (95% CI 0.73–0.94), and pooled specificity was 0.98 (95% CI 0.95–0.99; I 2 = 0%). The pooled DOR was 297.17 (95% CI 46.33–1906.19; p <0.0001). Sensitivity analyses showed stable results after sequential exclusion of individual studies. Conclusion: Twelve‐lead ECG algorithms provide high diagnostic performance for accessory pathway localization in manifest WPW and may be useful adjuncts for pre‐ablation planning, although invasive electrophysiological mapping remains essential.